Michael Rossi
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Rossi
Michael Rossi was last confirmed as CFO at Harvard Bioscience Inc (HBIO) in a filing dated April 5, 2023. Earlier roles on record: CFO at Harvard Bioscience Inc (HBIO) until December 31, 2022. Harvard Bioscience Inc reported in an 8-K filed January 19, 2023 that Michael Rossi resigned as Chief Financial Officer and Treasurer, effective December 31, 2022. Harvard Bioscience Inc reported in an 8-K filed December 12, 2022 that Michael Rossi resigned as Chief Financial Officer and Treasurer, effective December 31, 2022. The proxy statement of Harvard Bioscience Inc reports total compensation of $818,750 for Michael Rossi in fiscal 2021, including a base salary of $340,000. Disclosed compensation is on record for 3 fiscal years. Michael Rossi has spoken on 6 earnings calls across 1 company, most recently for Harvard Bioscience Inc on November 8, 2022.
“On December 7, 2022, Michael Rossi notified Harvard Bioscience, Inc. (the "Company") of his resignation as the Company's Chief Financial Officer and Treasurer effective December 31, 2022.”
“On December 7, 2022, Michael Rossi notified Harvard Bioscience, Inc. (the "Company") of his resignation as Chief Financial Officer and Treasurer, effective December 31, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-04-05
Last confirmed by a filing; no departure on record
-
Start not stated–2022-12-31
-
Start not stated–2022-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Harvard Bioscience Inc (HBIO) | Chief Financial Officer | $340,000 | $818,750 |
| 2020 | Harvard Bioscience Inc (HBIO) | Chief Financial Officer | $340,000 | $778,161 |
| 2019 | Harvard Bioscience Inc (HBIO) | Chief Financial Officer | $145,157 | $320,547 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.